EMERALD ADVISERS, LLC

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1015083 LEOLA, PA

Position in BBIO

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$38,270,707

-$2,709,881 QoQ

Shares Held

515,361

-3.8% QoQ

Ownership

0.263%

of shares outstanding

% of Portfolio

1.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 77% Shared 0% None 23%

Healthcare · as of Mar 31, 2026

EMERALD ADVISERS, LLC holds $427,347,303 across 25 Biotechnology names. BBIO ranks #3 (9.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COGT	Cogent Biosciences, Inc.	1,588,132	$61,127,200
2	TVTX	Travere Therapeutics, Inc.	1,557,196	$46,264,293
3	BBIO	BridgeBio Pharma, Inc. This page	515,361	$38,270,707
4	MIRM	Mirum Pharmaceuticals, Inc.	397,263	$36,699,155
5	SYRE	Spyre Therapeutics, Inc.	613,365	$30,938,130
6	NKTR	Nektar Therapeutics	394,604	$28,391,757
7	KALV	KalVista Pharmaceuticals, Inc.	1,264,023	$25,444,782
8	TRVI	Trevi Therapeutics, Inc.	1,839,566	$21,946,022

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$38,270,707	515,361	-3.8%	Shares	Sole	2026-05-04
2025-12-31	$40,980,588	535,764	-25.6%	Shares	Sole	2026-02-09
2025-09-30	$37,414,615	720,343	-29.5%	Shares	Sole	2025-10-30
2025-06-30	$44,097,877	1,021,257	-10.8%	Shares	Sole	2025-08-04
2025-03-31	$39,599,623	1,145,491	-0.5%	Shares	Sole	2025-05-01
2024-12-31	$31,579,817	1,150,868	+4.3%	Shares	Sole	2025-02-11
2024-09-30	$28,095,313	1,103,508	+65.6%	Shares	Sole	2024-10-29
2024-06-30	$16,878,493	666,344	-4.7%	Shares	Sole	2024-08-06
2024-03-31	$21,615,646	699,083	+2.0%	Shares	Sole	2024-05-08
2023-12-31	$27,675,209	685,539	-1.2%	Shares	Sole	2024-02-05
2023-09-30	$18,300,780	694,000	+44.8%	Shares	Sole	2023-10-26
2023-06-30	$8,240,950	479,125	—	Shares	Sole	2023-07-25
No filing history on record for this holder in this stock.